Prevention and Treatment of Tumor Lysis Syndrome

Expert perspectives on the prevention and treatment of tumor lysis syndrome (TLS) in patients on therapy for cancer.

EP. 1: Overview on Tumor Lysis Syndrome: Incidence and Risk Factors

January 18th 2023

Key opinion leaders James Short, MD, and John Reagan, MD, share an overview on the incidence and clinical risk factors of tumor lysis syndrome.

EP. 2: Identification of Tumor Lysis Syndrome: Signs and Symptoms

January 18th 2023

Comprehensive insight on the signs and symptoms that help lead to the identification of tumor lysis syndrome in patients receiving therapy for cancer.

EP. 3: Role of a Multidisciplinary Healthcare Team to Manage Tumor Lysis Syndrome

January 24th 2023

Shared insight on the multidisciplinary management of tumor lysis syndrome and how treatment planning may be adjusted after it is identified.

EP. 4: Prophylactic Measures to Prevent Tumor Lysis Syndrome

January 24th 2023

Expert perspectives on prophylactic measures to prevent tumor lysis syndrome in patients receiving therapy for cancer.

EP. 5: Guideline-Directed Treatment Options for Tumor Lysis Syndrome

January 31st 2023

James Short, MD, and John Reagan, MD, highlight guideline-indicated treatment options for patients with or at risk of tumor lysis syndrome.

EP. 6: Tumor Lysis Syndrome: Clinical Implications of Prophylaxis and Treatment

January 31st 2023

Experts James Short, MD, and John Reagan, MD, share comprehensive insight on the clinical implications of treating TLS in patients receiving therapy for cancer.

EP. 7: TLS Management in Academic vs Community Centers of Care

February 7th 2023

A brief review of the differences that might be observed between tumor lysis syndrome management in an academic versus community setting.

EP. 8: Tumor Lysis Syndrome: Unmet Needs and Future Directions in Care

February 7th 2023

Closing out their discussion on tumor lysis syndrome management, James Short, MD, and John Reagan, MD, highlight unmet needs and future evolutions in the treatment landscape.

EP. 9: An Overview on Tumor Lysis Syndrome in Cancer Care

February 14th 2023

Anthony Perissinotti, PharmD, BCOP, highlights associated risk for tumor lysis syndrome and identifies signs and symptoms.

EP. 10: Role of a Pharmacist in Managing Tumor Lysis Syndrome

February 14th 2023

Expert perspective on the role of a pharmacist in managing patients with identified tumor lysis syndrome.